Rapid Ebola Immunoassay From Corgenix Gains Authorization

The firm's ReEBOV assay, which can deliver results within 15-25 minutes, is the first rapid test and immunoassay for the Ebola virus granted an emergency use authorization by FDA.

More from Regulation

More from Policy & Regulation